For instance, PIM overexpression has been strongly associated with prostate cancer;21,22 indeed, one patient who received treatment in the solid tumour dose-escalation study had prostate cancer, and experienced a considerable reduction in PSA levels. Here, PIM1 is linked to prostate carcinoma.